Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating CD34<sup>+</sup> Fibroblast Progenitors Engaged in Heart Fibrosis of Allograft.

Circulation research·2026
Same author

Histone Lactylation Promotes Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure by Regulating TGFB2 Expression.

Circulation research·2025
Same author

Investigating intra-tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single-cell RNA sequencing.

Clinical and translational medicine·2024
Same author

The Prognostic Value of Serum Soluble Programmed Death 1 (sPD-1) and Programmed Death Ligand 1 (sPD-L1) in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis About Cohort Studies.

Health science reports·2024
Same author

TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway.

Cancer science·2022
Same author

The Oncogenic and Immunological Roles of Apoptosis Antagonistic Transcription Factors in Human Tumors: A Pan-Cancer Analysis.

Oxidative medicine and cellular longevity·2022

Related Experiment Videos

Innovative Advances in Non-Invasive Detection Technologies for Heart Failure: Synergistic Application of Multimodal

Yixin Chen1,2, Qiyao Yu3, Hongfei Xu3

  • 1Queen Mary College, Jiangxi Medical College, Nanchang University, 330006 Nanchang, Jiangxi, China.

Reviews in Cardiovascular Medicine
|July 8, 2026
PubMed
Summary

New AI-powered wearable sensors offer intelligent, non-invasive heart failure (HF) detection. These advanced technologies promise earlier diagnosis and personalized management, overcoming limitations of traditional methods for better patient outcomes.

Keywords:
artificial intelligenceheart failuremachine learningnon-invasive monitoringprecision medicinetelemedicinewearable electronic devices

Related Experiment Videos

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Artificial Intelligence

Background:

  • Heart failure (HF) is a major cause of mortality and disability, with diagnosis often delayed due to subtle symptoms.
  • Current diagnostic tools like echocardiography and BNP testing have limitations in accessibility and dynamic monitoring.
  • Aging populations are increasing the incidence of HF globally.

Purpose of the Study:

  • To systematically review heart failure pathophysiology and current monitoring strategies.
  • To critically evaluate emerging AI-driven, non-invasive HF detection devices and platforms.
  • To address challenges and propose future directions for intelligent HF diagnostics.

Main Methods:

  • Systematic review of scientific literature on HF.
  • Analysis of emerging non-invasive technologies integrating wearable sensors and AI.
  • Evaluation of data integration, clinical applicability, and underlying principles of new devices.

Main Results:

  • AI and cloud computing enable novel non-invasive HF detection using wearable sensors and multimodal platforms.
  • Technologies like ReDS™, HeartLogic™, and CardioSignal support real-time risk tracking and personalized HF management.
  • Rapid innovation, commercialization, and emergence of new products are driven by favorable policies and collaborations.

Conclusions:

  • Intelligent non-invasive devices represent a significant advancement in HF diagnostics.
  • Addressing AI challenges like data bias and privacy is crucial for widespread adoption.
  • Future directions include enhanced early screening, risk stratification, and precision interventions for HF.